Disposition of 4426 shares by Jude Onyia of Neurocrine Biosciences subject to Rule 16b-3
| 191216CT5 | 96.32 2.02 2.14% |
About 55% of 191216CT5's investors are presently thinking to get in. The analysis of the overall prospects from investing in COCA COLA CO suggests that some traders are, at the present time, interested. The current market sentiment, together with 191216CT5's historical and current headlines, can help investors time the market. In addition, many technical investors use COCA A CO bond news signals to limit their universe of possible portfolio assets.
191216CT5 |
Filed transaction by Neurocrine Biosciences Officer: Chief Scientific Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at thelincolnianonline.com
 |
191216CT5 Fundamental Analysis
We analyze 191216CT5's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of 191216CT5 using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of 191216CT5 based on its fundamental data. In general, a quantitative approach, as applied to this corporate bond, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Probability Of Bankruptcy
Probability Of Bankruptcy Comparative Analysis
COCA COLA cannot be rated in Probability Of Bankruptcy category at this point.Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
COCA A CO Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with 191216CT5 bond to make a market-neutral strategy. Peer analysis of 191216CT5 could also be used in its relative valuation, which is a method of valuing 191216CT5 by comparing valuation metrics with similar companies.
Peers
191216CT5 Related Equities
| 00108WAF7 | 00108WAF7 | 13.49 | ||||
| BMYMP | Bristol Myers | 7.23 | ||||
| GOOGL | Alphabet | 1.54 | ||||
| NBIX | Neurocrine Biosciences | 0.44 | ||||
| SAPMF | Saipem SpA | 0.00 | ||||
| BSIG | Brightsphere Investment | 0.04 | ||||
| TRT | Trio Tech | 0.97 | ||||
| 90331HPL1 | 90331HPL1 | 2.23 |
Other Information on Investing in 191216CT5 Bond
191216CT5 financial ratios help investors to determine whether 191216CT5 Bond is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 191216CT5 with respect to the benefits of owning 191216CT5 security.